AppLovin Posts 59% Revenue Surge in Q1 2026, Highlights AI-Driven Growth
AppLovin Corporation (NASDAQ: APP) announced its first‑quarter 2026 financial results on May 6, 2026, reporting a 59 %...
Read story →Tag: Axon
View all →
Revolution Medicines' Daraxonrasib Shows Dramatic Survival Benefit in Metastatic Pancreatic Cancer
Revolution Medicines (NASDAQ: RVMD) announced on April 13, 2026 that its oral RAS inhibitor, daraxonrasib, produced a st...
Read story →
Motorola Solutions Acquires Israeli Counter-Drone Firm D-Fend for $1.5 B
On June 1, 2026, Motorola Solutions (NYSE: MSI) announced a definitive agreement to acquire Israeli counter‑drone spec...
Read story →